BusinessMelissa Enables Real-Time Identity Verification in Global BankingBy Nasdaq OMXNov 8, 2017, 1:01 PM UTC
BusinessCyclacel Pharmaceuticals Announces That Full Results From the Phase 3 Seamless Trial Have Been Selected for Oral Presentation at ASH 2017 Annual MeetingBy Nasdaq OMXNov 1, 2017, 1:02 PM UTC
BusinessKura Oncology Development Candidate KO-539 Shows Robust Preclinical Anti-Tumor Activity in NPM1- and DNMT3A-Mutant AMLBy Nasdaq OMXOct 28, 2017, 4:30 PM UTC
BusinessOnconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 15, 2017, 11:00 AM UTC
BusinessInvivoscribe® Releases LeukoStrat® CDx FLT3 Mutation Assay as CE-marked IVD Assay KitBy Nasdaq OMXAug 1, 2017, 10:00 AM UTC
